Torii Pharmaceutical Co Ltd
TSE:4551
Torii Pharmaceutical Co Ltd
TSE:4551
Price:
4 555
JPY
4.59%
Market Closed
Market Cap:
128B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Torii Pharmaceutical Co Ltd
4555
+200 (+4.59%)
| 52 Week Range |
3 215
4 555
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Torii Pharmaceutical Co Ltd
Balance Sheet
Balance Sheet Decomposition
Torii Pharmaceutical Co Ltd
Torii Pharmaceutical Co Ltd
| Current Assets | 87.2B |
| Cash & Short-Term Investments | 42.2B |
| Receivables | 27.9B |
| Other Current Assets | 17.1B |
| Non-Current Assets | 47.2B |
| Long-Term Investments | 35.3B |
| PP&E | 2.1B |
| Intangibles | 375m |
| Other Non-Current Assets | 9.5B |
| Current Liabilities | 13.2B |
| Accounts Payable | 8.6B |
| Accrued Liabilities | 433m |
| Other Current Liabilities | 4.2B |
| Non-Current Liabilities | 694m |
| Other Non-Current Liabilities | 694m |
Balance Sheet
Torii Pharmaceutical Co Ltd
Torii Pharmaceutical Co Ltd
Currency: JPY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
6 316
|
14 361
|
22 393
|
6 458
|
3 484
|
5 773
|
3 717
|
4 012
|
9 203
|
5 004
|
|
| Cash Equivalents |
6 316
|
14 361
|
22 393
|
6 458
|
3 484
|
5 773
|
3 717
|
4 012
|
9 203
|
5 004
|
|
| Short-Term Investments |
13 209
|
18 708
|
11 102
|
24 957
|
28 606
|
33 150
|
38 528
|
38 198
|
38 489
|
38 999
|
|
| Total Receivables |
25 901
|
27 904
|
26 560
|
29 122
|
27 137
|
25 150
|
18 955
|
22 010
|
22 865
|
28 502
|
|
| Accounts Receivables |
25 894
|
27 897
|
26 553
|
29 108
|
27 137
|
25 136
|
18 948
|
22 010
|
22 865
|
28 488
|
|
| Other Receivables |
7
|
7
|
7
|
14
|
0
|
14
|
7
|
0
|
0
|
14
|
|
| Inventory |
10 135
|
9 835
|
10 606
|
10 125
|
8 313
|
7 513
|
7 151
|
8 763
|
8 969
|
10 742
|
|
| Other Current Assets |
16 560
|
6 347
|
9 462
|
13 318
|
10 913
|
38 431
|
28 391
|
24 309
|
12 077
|
4 901
|
|
| Total Current Assets |
72 121
|
77 155
|
80 123
|
83 980
|
78 453
|
110 017
|
96 742
|
97 292
|
91 603
|
88 148
|
|
| PP&E Net |
5 806
|
6 182
|
5 752
|
5 540
|
3 431
|
2 778
|
1 777
|
2 078
|
2 282
|
2 095
|
|
| PP&E Gross |
5 806
|
6 182
|
5 752
|
5 540
|
3 431
|
2 778
|
1 777
|
2 078
|
2 282
|
2 095
|
|
| Accumulated Depreciation |
18 010
|
18 245
|
18 959
|
19 541
|
19 592
|
19 295
|
4 263
|
4 343
|
4 591
|
4 851
|
|
| Intangible Assets |
818
|
955
|
896
|
817
|
669
|
526
|
442
|
512
|
517
|
429
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
7 070
|
6 800
|
3 877
|
7 478
|
13 770
|
19 764
|
20 810
|
22 309
|
30 282
|
33 970
|
|
| Other Long-Term Assets |
6 734
|
7 776
|
7 877
|
6 926
|
6 930
|
6 858
|
6 255
|
8 619
|
9 005
|
8 790
|
|
| Total Assets |
92 550
N/A
|
98 868
+7%
|
98 525
0%
|
104 741
+6%
|
103 253
-1%
|
139 943
+36%
|
126 026
-10%
|
130 810
+4%
|
133 689
+2%
|
133 432
0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
6 095
|
6 853
|
6 698
|
8 242
|
6 657
|
5 752
|
5 143
|
5 793
|
6 584
|
6 981
|
|
| Accrued Liabilities |
1 773
|
1 370
|
1 376
|
1 482
|
1 495
|
828
|
689
|
812
|
753
|
931
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
331
|
342
|
199
|
85
|
85
|
85
|
85
|
211
|
283
|
222
|
|
| Other Current Liabilities |
3 192
|
5 907
|
5 037
|
6 059
|
6 037
|
18 277
|
3 544
|
5 556
|
5 601
|
4 370
|
|
| Total Current Liabilities |
11 391
|
14 472
|
13 310
|
15 868
|
14 274
|
24 942
|
9 461
|
12 372
|
13 221
|
12 504
|
|
| Long-Term Debt |
387
|
725
|
571
|
465
|
380
|
294
|
209
|
275
|
241
|
22
|
|
| Other Liabilities |
547
|
845
|
1 088
|
1 289
|
1 507
|
1 582
|
1 265
|
1 148
|
1 003
|
772
|
|
| Total Liabilities |
12 325
N/A
|
16 042
+30%
|
14 969
-7%
|
17 622
+18%
|
16 161
-8%
|
26 818
+66%
|
10 935
-59%
|
13 795
+26%
|
14 465
+5%
|
13 298
-8%
|
|
| Equity | |||||||||||
| Common Stock |
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
5 190
|
|
| Retained Earnings |
69 102
|
71 384
|
72 870
|
76 247
|
76 067
|
102 087
|
104 234
|
106 250
|
108 846
|
109 425
|
|
| Additional Paid In Capital |
6 416
|
6 416
|
6 416
|
6 416
|
6 426
|
6 429
|
6 437
|
6 445
|
6 453
|
6 460
|
|
| Unrealized Security Profit/Loss |
377
|
698
|
558
|
745
|
864
|
850
|
636
|
523
|
117
|
427
|
|
| Treasury Stock |
861
|
863
|
1 478
|
1 480
|
1 455
|
1 431
|
1 407
|
1 393
|
1 381
|
1 369
|
|
| Other Equity |
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Total Equity |
80 225
N/A
|
82 826
+3%
|
83 556
+1%
|
87 119
+4%
|
87 092
0%
|
113 125
+30%
|
115 091
+2%
|
117 015
+2%
|
119 224
+2%
|
120 134
+1%
|
|
| Total Liabilities & Equity |
92 550
N/A
|
98 868
+7%
|
98 525
0%
|
104 741
+6%
|
103 253
-1%
|
139 943
+36%
|
126 026
-10%
|
130 810
+4%
|
133 689
+2%
|
133 432
0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
